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The search for psychosocial factors that contribute to the aetiology and course of coronary heart 
disease (CHD) has been an energetic, although not always fruitful, pursuit for more than half a 
century. Around 20 years ago, Appels [1] identified a prodromal constellation of symptoms, 
including physical exhaustion and feelings of hopelessness, that preceded major CHD events. It 
was hypothesized that this syndrome of bvital exhaustion Q (VE) was a causal risk factor 
for CHD events, and several observational studies demonstrating prospective associations 
between VE and subsequent events have been adduced as supporting the hypothesis [2–5]. In a 
recent commentary, however, we discussed the difficulties inherent in drawing causal 
conclusions from observational evidence [6]. Applying general arguments that are by now very 
well rehearsed [7,8], we suggested that considerations such as confounding by common 
antecedents of both VE and CHD and reverse causation could not be readily dismissed and 
resolution was likely only following experimental studies. For example, an explanation of these 
prospective associations that regards CHD events as the result of inflammatory processes 
involved in the progress of atherosclerosis and VE as a consequence of such processes is just as 
parsimonious as one that regards VE as a causal risk. It is also equally, if not more, plausible 
biologically; there is now substantial evidence that inflammatory cytokines communicate with 
the central nervous system contributing to illness behaviour and experience and fostering 
feelings of depression and fatigue [9]. We also posed the question of what implications do the 
results of observational studies of VE hold for treatment [6]. Again, we would argue that in 
the absence of experimental evidence, the implications are extremely limited. 
Accordingly, the experimental evidence presented by Appels et al. [10] from the Exhaustion 
Intervention Trial (EXIT) in the paper published in this issue and its companion article published 
recently in Psychosomatic Medicine [11] is to be very much welcomed. Over 4000 CHD patients 
who had undergone successful angioplasty were approached. Refusal to participate and absence 
of VE reduced the sample to just over 700 who were randomized either to a 6-month exhaustion 
intervention comprising, among other things, group counseling, stress and anger management, 
and relaxation, or to a usual care control condition, largely involving routine check-ups. The 
earlier publication focused on recurrent CHD events. Vital exhaustion measured at 6 months, i.e., 
immediately after the intervention, did not differ between intervention and control. 
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By 18-month follow-up, however, fewer intervention patients reported feeling exhausted; they 
were also, following statistical adjustment for age, gender, and depression status at intake, less 
likely to be depressed at 18 months.  Nevertheless, the intervention did not reduce the likelihood 
of patients having a recurrent CHD event, a result which is very much in line with findings from 
the recent ENRICHD trial that reductions in mortality and recurrent events did not follow from 
the successful treatment of depression in CHD patients [12]. Appels et al [11] concluded that, 
these negative outcomes do not refute the strong predictive power of depressive symptomatology 
or exhaustion observed in many studies, nor do they refute the biological plausibility of this 
association Q (p. 222). We would submit that they were being unduly modest and that their 
results and those from ENRICHD should cause us to pause, reconsider the issue of causality, and 
examine alternative, biologically plausible, explanations for the patterns of results that have 
emerged from observational studies. Although event-free survival will necessarily remain a 
key consideration in managing CHD, other outcomes, particularly quality of life, should not be 
disregarded. In an editorial in an earlier volume of Psychosomatic Medicine, Lesperance and 
Frasure-Smith [13] argued cogently that, we should not lose sight of the fact that an intervention 
that improves well-being, but fails to change survival, is still a very valuable treatment Q (p. 20). 
It is to Appels and his colleagues’ [10] credit that, in addition to recurrent CHD events, they 
measured such well-being outcomes in EXIT; these constitute the focus of their article in this 
issue. The outcomes reported, aside from depression which is mentioned above, are health-
related quality of life, anxiety, anger, and anginal complaints. The intervention, despite including 
treatment for anger, failed to modify scores on the questionnaire measurement of anger. Effects 
are reported for the other outcomes, but they are not always easy to interpret. Intervention and 
control groups showed virtually identical mean health-related quality of life scores at both the 6-
month and 18-month sampling points. However, the intervention group registered poorer quality 
of life at entry to the study and from multiple linear regression, adjusting for age, gender, history 
of CHD, and comorbidity; in addition to baseline quality of life, the intervention is reported to 
improve quality of life at 18-month follow-up. Anxiety levels did not improve with treatment, 
but a treatment by gender by time analysis of variance interaction is reported that did not meet 
the conventional criterion for statistical significance, with subsequent post hoc analyses 
indicating that the intervention appeared to be anxiolytic for women. Adjusting for age, 
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gender, and comorbidity, but somewhat surprisingly not for whether patients complained of 
angina at baseline, fewer patients in the intervention group reported anginal complaints 
at the 18-month follow-up. In contrast to the restraint exercised when discussing the implications 
of the null findings in their earlier article, the present results are summarised as a consistent 
picture of treatment-facilitated benefit and improvement in well-being. However, the 
effects are invariably small, a matter conceded by the authors; they are also somewhat 
haphazardly manifest, appearing after somewhat varying adjustment strategies and 
are sometimes present only in subsamples of patients. Indeed, far from suggesting a successful 
intervention, the present results are less coherent than might be expected from the usual inter-
correlations among the outcome variables. Vital exhaustion is strongly correlated with both 
quality of life and depression; depression is strongly correlated with both quality of life and 
anxiety. The assessment of angina symptoms is subject to reporting bias linked to negative 
affectivity [14], which, in turn, is correlated with anxiety. Improving the psychosocial status 
of CHD patients is an important but often poorly heeded clinical imperative and EXIT is to be 
lauded for its intent. However, the results are hardly compelling advertisement for this kind of 
treatment. We base this conclusion not on the failure of the intervention to affect the recurrence 
of CHD events but on its modest and inconsistent effectiveness in improving psychological well-
being. 
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